BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24007656)

  • 1. Increased Toll-like receptor 9 expression by B cells from inflammatory bowel disease patients.
    Berkowitz D; Peri R; Lavy A; Kessel A
    Hum Immunol; 2013 Dec; 74(12):1519-23. PubMed ID: 24007656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
    Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation.
    Månsson A; Adner M; Höckerfelt U; Cardell LO
    Immunology; 2006 Aug; 118(4):539-48. PubMed ID: 16780564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells.
    Baumgart DC; Metzke D; Schmitz J; Scheffold A; Sturm A; Wiedenmann B; Dignass AU
    Gut; 2005 Feb; 54(2):228-36. PubMed ID: 15647187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
    Pedersen G; Andresen L; Matthiessen MW; Rask-Madsen J; Brynskov J
    Clin Exp Immunol; 2005 Aug; 141(2):298-306. PubMed ID: 15996194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
    Abu-Rish EY; Amrani Y; Browning MJ
    Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell-activating factor enhances interleukin-6 and interleukin-10 production by ODN-activated human B cells.
    Yehudai D; Snir A; Peri R; Halasz K; Haj T; Odeh M; Kessel A
    Scand J Immunol; 2012 Oct; 76(4):371-7. PubMed ID: 22725135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR9 signaling failure renders Peyer's patch regulatory B cells unresponsive to stimulation with CpG oligodeoxynucleotides.
    Booth JS; Arsenault R; Napper S; Griebel PJ; Potter AA; Babiuk LA; Mutwiri GK
    J Innate Immun; 2010; 2(5):483-94. PubMed ID: 20551621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
    Gantner F; Hermann P; Nakashima K; Matsukawa S; Sakai K; Bacon KB
    Eur J Immunol; 2003 Jun; 33(6):1576-85. PubMed ID: 12778475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species-Specific Minimal Sequence Motif for Oligodeoxyribonucleotides Activating Mouse TLR9.
    Pohar J; Lainšček D; Fukui R; Yamamoto C; Miyake K; Jerala R; Benčina M
    J Immunol; 2015 Nov; 195(9):4396-405. PubMed ID: 26416273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population.
    Wu O; Chen GP; Chen H; Li XP; Xu JH; Zhao SS; Sheng J; Feng JB; Cai J; Fang XH; Zhang WH; Li LH; Zhang N; Li J; Li JJ; Pan FM; Wang CZ; Ye DQ
    Immunobiology; 2009; 214(5):392-402. PubMed ID: 19362685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin M memory B cell decrease in inflammatory bowel disease.
    Di Sabatino A; Carsetti R; Rosado MM; Ciccocioppo R; Cazzola P; Morera R; Tinozzi FP; Tinozzi S; Corazza GR
    Eur Rev Med Pharmacol Sci; 2004; 8(5):199-203. PubMed ID: 15638230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn's disease.
    Rabe H; Malmquist M; Barkman C; Östman S; Gjertsson I; Saalman R; Wold AE
    Clin Exp Immunol; 2019 Jul; 197(1):111-129. PubMed ID: 30883691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of peripheral blood CD5+ B cells in inflammatory bowel disease.
    Mishima Y; Ishihara S; Amano Y; Oshima N; Kadota C; Otani A; Moriyama I; Li YY; Aziz MM; Kinoshita Y
    Scand J Gastroenterol; 2009; 44(2):172-9. PubMed ID: 18830898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired toll-like receptor 9 expression in alveolar macrophages with no sensitivity to CpG DNA.
    Suzuki K; Suda T; Naito T; Ide K; Chida K; Nakamura H
    Am J Respir Crit Care Med; 2005 Apr; 171(7):707-13. PubMed ID: 15640365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level.
    Jurk M; Schulte B; Kritzler A; Noll B; Uhlmann E; Wader T; Schetter C; Krieg AM; Vollmer J
    Immunobiology; 2004; 209(1-2):141-54. PubMed ID: 15481148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseases.
    Defendenti C; Atzeni F; Malandrin S; Ardizzone S; Almasio PL; Saibeni S; Bezzio C; Bollani S; Salerno R; Declich P; Sarno Z; Bruno S; Talotta R; Sarzi-Puttini P
    Int Immunopharmacol; 2018 Jan; 54():329-335. PubMed ID: 29197269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating memory B cells and plasmablasts are associated with the levels of serum immunoglobulin in patients with ulcerative colitis.
    Wang X; Jiang Y; Zhu Y; Zhang M; Li M; Wang H; Gao P
    J Cell Mol Med; 2016 May; 20(5):804-14. PubMed ID: 26800315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.